Filing Details
- Accession Number:
- 0001645627-17-000110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-25 20:42:22
- Reporting Period:
- 2017-08-21
- Accepted Time:
- 2017-08-25 19:42:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-21 | 3,000 | $0.03 | 22,533,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 5,000 | $0.03 | 22,538,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 5,000 | $0.03 | 22,543,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 5,000 | $0.03 | 22,548,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 3,000 | $0.03 | 22,551,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 3,000 | $0.03 | 22,554,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 5,000 | $0.03 | 22,559,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 3,000 | $0.03 | 22,562,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 5,000 | $0.03 | 22,567,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 5,000 | $0.03 | 22,572,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-21 | 3,000 | $0.03 | 22,575,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 3,000 | $0.03 | 22,578,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 3,000 | $0.03 | 22,581,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 3,000 | $0.03 | 22,584,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 3,000 | $0.03 | 22,587,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 3,000 | $0.03 | 22,590,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 3,000 | $0.03 | 22,593,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 3,000 | $0.03 | 22,596,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 5,000 | $0.03 | 22,601,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 3,000 | $0.03 | 22,604,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 3,000 | $0.02 | 22,607,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 5,000 | $0.02 | 22,612,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 3,000 | $0.02 | 22,615,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 5,000 | $0.02 | 22,620,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 2,000 | $0.02 | 22,622,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 10,000 | $0.02 | 22,632,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 3,000 | $0.02 | 22,635,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 3,000 | $0.02 | 22,638,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 3,000 | $0.02 | 22,641,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 3,000 | $0.02 | 22,644,889 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
